PDM

Xcell Biosciences Appoints Shannon Eaker, Ph.D. as Chief Technology Officer

Retrieved on: 
Tuesday, May 3, 2022
Science, Stem Cells, Software, Other Science, Biotechnology, Pharmaceutical, Health, Technology, Shannon, Cell biology, Process, University, GE Healthcare, Automation, Regenerative medicine, Cell, TME, Software, Safety, HSC, IPS, ISCT, Gene, Industry, CEO, International Society, Research, PDM, Growth, Molecular biology, Multimedia, Vaccine, Pharmaceutical industry, Biochemistry

Xcell Biosciences Inc. (Xcellbio), an automation and instrumentation company focused on cell therapy manufacturing, today announced the appointment of Shannon Eaker, Ph.D., as its Chief Technology Officer.

Key Points: 
  • Xcell Biosciences Inc. (Xcellbio), an automation and instrumentation company focused on cell therapy manufacturing, today announced the appointment of Shannon Eaker, Ph.D., as its Chief Technology Officer.
  • View the full release here: https://www.businesswire.com/news/home/20220503005385/en/
    Xcellbio has appointed Shannon Eaker, Ph.D., as its Chief Technology Officer.
  • He joins Xcellbio from Cytiva (formerly GE Healthcare) Cell and Gene Therapy where he spent more than 11 years.
  • Xcellbio has made incredible progress in delivering robust, high-value cell and gene therapy development technologies to labs around the world, said Dr. Eaker.

Piedmont Office Realty Trust Reports First Quarter 2022 Results

Retrieved on: 
Wednesday, April 27, 2022
Tenant, Core, Internal Revenue Code, NYSE, U.S. Securities and Exchange Commission, S&P Global Ratings, Securities Act of 1933, Terrorism, George French Angas, LIBOR, Internal Revenue Code section 1031, Securities Exchange Act of 1934, Public health, PDM, Investment, GAAP, Public expenditure, Forward-looking statement, COVID-19, Technology, Risk, BBB, BAA2, Travel, Company, Acquisition, Annual report, Phrase, Security (finance), News, London Interbank Bid Rate, Investor relations, Net income, Sun Belt, REIT, Insurance, NAREIT, FFO, Real estate investment trust, Maintenance, Risk management, Depreciation

In addition, the Company's guidance is based on information available to management as of the date of this release.

Key Points: 
  • In addition, the Company's guidance is based on information available to management as of the date of this release.
  • Piedmont has scheduled a conference call and an audio web cast for Thursday, April 28, 2022 at 9:00 A.M. Eastern daylight time.
  • During the audio web cast and conference call, the Company's management team will review first quarter 2022 performance, discuss recent events, and conduct a question-and-answer period.
  • Piedmont Office Realty Trust, Inc. (NYSE: PDM) is an owner, manager, developer, redeveloper, and operator of high-quality, Class A office properties located primarily in the Sunbelt.

LexisNexis Risk Solutions Named a Leader in IDC MarketScape Report on U.S. Provider Data Management for Payers

Retrieved on: 
Tuesday, April 19, 2022
Diamond, Health, Data management, Government, LSE, IDC, Telecommunication, Software, ICT, Patient satisfaction, LexisNexis Risk Solutions, Payment, Health care, Technology, Insurance, Solution, General manager, RELX, PDM, Data science, Multimedia, Risk, Risk management

ATLANTA, April 19, 2022 /PRNewswire/ -- LexisNexis® Risk Solutions, the premier provider of healthcare data and identity verification solutions, has been named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2022 Vendor Assessment1. The report notes, "LexisNexis Risk Solutions' commitment to cleansed, quality provider data is outstanding and evident."

Key Points: 
  • ATLANTA, April 19, 2022 /PRNewswire/ -- LexisNexis Risk Solutions , the premier provider of healthcare data and identity verification solutions, has been named a Leader in the IDC MarketScape: U.S.
  • The report notes, "LexisNexis Risk Solutions' commitment to cleansed, quality provider data is outstanding and evident."
  • This IDC MarketScape study assesses the capability and business strategy of many of the most prominent provider data management (PDM) vendors found in payers that use that software to establish a "core provider system of record or truth" for the payer enterprise.
  • "This is indeed an impressive set of pure provider data management functionality; its approach to volume, quality, completeness, coverage, and mandate compliance is notable."

Groupe Chantelle Selects Centric PLM™ to Digitize Product Development and Empower Omnichannel Strategy

Retrieved on: 
Tuesday, April 19, 2022
Food, Corporate social responsibility, CEO, Kretz, Data management, Marketing, Centric, Microsoft Excel, Transport, Collection, CSR, Goal, Budget, Cosmetics, Livera, PLM, Stock, Centric Software, Technology, Chantelle, Google Drive, Customer service, Product lifecycle, Digital, PDM, Master data, Design

CAMPBELL, Calif., April 19, 2022 /PRNewswire/ -- Groupe Chantelle, the French lingerie giant, has selected Centric Software's Product Lifecycle Management (PLM) solution. Centric Software provides the most innovative enterprise solutions to plan, design, develop, source and sell products such as apparel, footwear, sporting goods, furniture, home décor, cosmetics, food & beverage and luxury to achieve strategic and operational digital transformation goals.

Key Points: 
  • CAMPBELL, Calif., April 19, 2022 /PRNewswire/ --Groupe Chantelle, the French lingerie giant, has selected Centric Software's Product Lifecycle Management (PLM) solution.
  • Today, Chantelle has 4,000 employees worldwide and owns six brands Chantelle, Passionata, Chantelle X, Femilet, Livera, and Darjeeling.
  • Chantelle expects PLM to streamline the product development process, enable more effective control of the material certification process, support planning and improve stock management accuracy.
  • "With Centric PLM, Chantelle will be empowered to seamlessly manage supply chains and achieve ambitious CSR goals."

Piedmont Office Realty Trust, Inc to Report First Quarter 2022 Financial Results

Retrieved on: 
Tuesday, April 12, 2022
NYSE, Conference, Replay, PDM, Company, GLOBE, New, Broadcasting, Pharmaceutical industry, Webcast

Atlanta, April 12, 2022 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust (NYSE: PDM) announced today that the Company will release its first quarter financial results on Wednesday, April 27, 2022, after the close of trading on the New York Stock Exchange.

Key Points: 
  • Atlanta, April 12, 2022 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust (NYSE: PDM) announced today that the Company will release its first quarter financial results on Wednesday, April 27, 2022, after the close of trading on the New York Stock Exchange.
  • A conference call is scheduled for Thursday, April 28, 2022, at 9:00 a.m. Eastern daylight time and will be broadcast live in listen-only mode on the companys investor relations website at investor.piedmontreit.com.
  • During the conference call, the Companys management team will review first quarter performance, discuss recent events, and conduct a question-and-answer period.
  • To Listen to the Replay via Webcast:
    To Listen to the Replay Telephonically:

University of Nottingham Ningbo China Students Win International Award With Cutting Edge Design

Retrieved on: 
Friday, April 8, 2022
Fashion, Seniors, Environment, Retail, Other Science, Research, Software, Networks, Medical Devices, Hardware, Consumer, Data Management, Science, Technology, General Health, Health, University, Education, Exercise, University, Population, IDA, University of Nottingham Ningbo China, 3D, RCA, Puma, Ageing, Industry, Technology, International, Architecture, PDM, Student, University of Nottingham, Photography, MIT, Medicine, Adidas

University of Nottingham Ningbo China students have designed cutting edge wearable technology to monitor and record the health data, enabling the best possible care for senior citizens.

Key Points: 
  • University of Nottingham Ningbo China students have designed cutting edge wearable technology to monitor and record the health data, enabling the best possible care for senior citizens.
  • The Global Footwear Awards was founded by the Farmani Group, an organisation behind various competitions in the domains of design, architecture and photography (for example IDA, International Design Award).
  • Using 3D knitting and pressure technology, the design is cutting edge and a departure from most designs that have pressure sensors directly attached to them.
  • Academic staff in the PDM programme are committed to providing students with more industry related design projects, helping students to gain an in-depth understanding of the whole product design cycle.

Madaket Health Now Available in AWS Marketplace

Retrieved on: 
Thursday, April 7, 2022
Technology, Professional Services, Software, Internet, Managed Care, Health, Data Management, Retail, Online Retail, Other Professional Services, PDM, Entrepreneurship, Health, AWS, Solution, Credentialing, Madaket, Massachusetts, Data management, Â, Patient, Amazon Web Services, Online shopping

Through our availability in AWS Marketplace , were able to serve additional customers directly through their cloud services and management provider, said Eric Demers, Chief Executive Officer at Madaket Health.

Key Points: 
  • Through our availability in AWS Marketplace , were able to serve additional customers directly through their cloud services and management provider, said Eric Demers, Chief Executive Officer at Madaket Health.
  • Through our availability in AWS Marketplace, well further our work as we expand support to additional leaders who are looking to innovate the business of healthcare.
  • To learn more about how market leaders use Madaket to streamline provider data management, view Madaket Health in AWS Marketplace or visit madakethealth.com .
  • Madaket Health offers a modern approach to provider data management.

Improving Announces Creation of New Microsoft Team

Retrieved on: 
Monday, April 4, 2022
Cloud, CSP, Improper integral, Partnership, Investment, Partner development, CEO, Specialist, Azure, Time, PDM, History, Java, Video game console, Microsoft, Agile

To support the tremendous company growth around the Microsoft practice, a new corporate team has been created to focus on the partnership with Microsoft.

Key Points: 
  • To support the tremendous company growth around the Microsoft practice, a new corporate team has been created to focus on the partnership with Microsoft.
  • The Improving Microsoft Services Team will work closely with each Improving enterprise to ensure they are maximizing the value of the Microsoft Partnership and assisting clients to do the same for the investments they are making in Microsoft technologies.
  • Improving, a modern digital services company, creates a Microsoft Services Team.
  • I'm thrilled to have the opportunity to continue the relationships we have today and replicate that trust into additional resources at Microsoft for Improving," said Messner, Sr. VP Microsoft Services Team.

Geisinger, Eisai team up to study use of artificial intelligence for early detection and identification of cognitive impairment that could indicate dementias, including Alzheimer's disease

Retrieved on: 
Monday, April 4, 2022
Dementia, Risk, LinkedIn, Milken Institute, Greater, Indiana University, Neurology, Government budget balance, Diagnosis, AD, Neurodegeneration, Caregiver, Informatics, Research, Krembil Research Institute, Alzheimer's Disease International, Geisinger Commonwealth School of Medicine, AI, Cancer, Intelligence, Integrity, Quality of life, Health, Artificial intelligence, Association, Purdue University, Technology, Ageing, Twitter, PDM, Data, Gerontology, Physician, Instagram, Eisai, Patient, Medical device, Residential care, Medical imaging, Pharmaceutical industry, Geisinger, Alzheimer's disease, Facebook

DANVILLE, Pa. and NUTLEY, N.J., April 4, 2022 /PRNewswire/ -- Geisinger and Eisai Inc. today announced a collaborative effort to study the potential effectiveness of an artificial intelligence (AI) tool in the detection of cognitive impairment that could identify dementias, including Alzheimer's disease (AD). If effective, the AI tool could potentially be developed to support the early detection and staging of cognitive impairment and dementia, leading to appropriate additional testing for the clinical, biological diagnosis and treatment of dementias such as AD.

Key Points: 
  • The research collaboration will study the use of an algorithm trained on a set of de-identified patient data to identify individuals likely to have cognitive impairment.
  • The algorithm, known as a Passive Digital Marker (PDM), was developed and tested by researchers at Purdue University and Indiana University.
  • The Geisinger-Eisai team will evaluate the PDM in Geisinger's de-identified dataset to determine its potential to detect cognitive impairment, which may suggest early signs of dementia.
  • "Early and accurate diagnosis and treatment of these conditions can drastically improve outcomes and quality of life for both patients and caregivers."

Clarus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

Retrieved on: 
Wednesday, March 30, 2022
Chronic kidney disease, Therapy, LinkedIn, Investor, Marketing, Hypogonadism, ID, Growth, Testosterone, Advertising, Annual report, Research, SEC, Coenzyme Q10, Woman, Adam, Conference call, Failure, Man, U.S. Securities and Exchange Commission, Workforce, Prospectus, Twitter, CKD, PDM, COVID-19, Male, GLOBE, McGill, Income, Solution, Caspofungin, Degenerative disease, Patient, Security (finance), Pharmaceutical industry, Animal, Risk management, Conference

NORTHBROOK, Ill., March 30, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today reported financial results for the fourth quarter and full year of 2021.

Key Points: 
  • ET
    NORTHBROOK, Ill., March 30, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today reported financial results for the fourth quarter and full year of 2021.
  • Our cash and cash equivalents as of December 31, 2021 will fund our current operating plan into approximately April 2022.
  • A live webcast and replay of the conference call will be accessible through the Investors section of Clarus Therapeutics website at Investors.ClarusTherapeutics.com .
  • The following presents Clarus Therapeutics Holdings, Inc. statements of operations for the three and twelve months ended December 31, 2021 and 2020: